PSA screening aids in decreasing prostate cancer death by 40 percent

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

One in seven men in the U.S. will be diagnosed with prostate cancer at some point in their lifetime, and one in thirty-five men will die from the disease.

The Prostate-Specific Antigen (PSA) Test, while not fool-proof, has been widely used to screen men for prostate cancer.

Since doctors began PSA screening, the incidence of prostate cancer deaths has decreased by 40 percent.

The team of medical experts within the Cone Health network recommends that men between the ages of 50 to 70 who have a ten year life expectancy or greater should receive PSA screening.cancer

It is especially important for African American men and men with a family history of the disease that fall within this age range to get screened, as they are at higher risk for developing prostate cancer.

Because prostate cancer is the most common cancer among men, building awareness about the disease and PSA screening is of utmost importance.

Throughout the next few months, Cone Health will be hosting and sponsoring several events in an effort to educate the community about the disease, offer screenings and raise funds toward prostate cancer research:

- Monday, August 18th - Cancer Prevention Series - Prostate Cancer: What You Need to Know Register at
- Free Prostate Cancer Screenings throughout the month of September and October in various locations. To find locations and register:
- Saturday, November 15th – Prostate Cancer 5K Run/Walk – Register at

Spokesperson Background:
Dr. Ted Manny is a urologist at Alliance Urology and a member of the Cone Health medical staff.

Dr. Manny is a 2007 medical school graduate of the University of Texas Southwestern. He completed his residency in urology and a fellowship in robotics at Wake Forest University Baptist Medical Center.